secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROCEPT BioRobotics Corp (PRCT)
CIK:        0001588978
Form:       8-K
Filed at:   2025-08-06T23:59:59+00:00
Accession:  0001588978-25-000041
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PROCEPT Q2 revenue $79.2M (+48% YoY); raises FY25 guidance; appoints new CEO
----------------------------------------------------------------------------

- Q2 total revenue $79.2M, up 48% YoY; U.S. handpiece/consumables $43.1M (+58%).
- Net loss improved to $19.6M from $25.6M; Adjusted EBITDA loss $8.0M (vs. $17.9M loss prior year).
- Gross margin expanded to 65% from 59% due to operational efficiencies and higher system ASP.
- Raises FY 2025 revenue guidance to $325.5M (45% growth) from prior $323.0M; expects 64.5% gross margin.
- Appoints Larry Wood as CEO effective Sept. 2, 2025; brings 40 years medtech leadership.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1588978/000158897825000041/0001588978-25-000041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1588978/000158897825000041/prct-20250806.htm
  HTML page:      https://secwatch.observer/filing/0001588978-25-000041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer